|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received January 23, 2007
Revised February 17, 2007
Accepted after revision March 1, 2007
1 The Pennsylvania State University
2 Noll Physiological Research Center
* To whom correspondence should be addressed. E-mail: lma191{at}psu.edu.
Reflex cutaneous vasodilatation is dependent on nitric oxide (NO), which is diminished in hypertension (HTN). Arginase may be upregulated with HTN, which preferentially metabolizes L-arginine (L-arg), competing with NO-synthase-mediated pathways and limiting NO synthesis. We hypothesized that NO-dependent vasodilatation would be attenuated in HTN skin, and arginase inhibition (A-I) alone or with concurrent L-arginine supplementation, would augment vasodilatation. Five microdialysis fibres were placed in skin of 8 unmedicated subjects with HTN (MAP: 112±1 mmHg) and 9 age-matched normotensive (AMN) (MAP: 87±1 mmHg) men and women to serve as: control (C: Ringers), NOS inhibited (NOS-I: 10mM L-NAME), A-I (5mM BEC + 5mM nor-NOHA), L-arg supplemented (L-arg: 10mM L-arg), and combined A-I + L-arg. Reflex vasodilatation was induced by using a water-perfused suit to increase oral temperature (Tor) 1.0°C. Red cell flux was measured by laser-Doppler over each site. Cutaneous vascular conductance was calculated (CVC=flux/MAP) and normalized to maximal CVC (28mM SNP + local heating to 43°C). The Ä%CVCmax between the control and NOS-I site was calculated as the difference between Co and NOS-I sites. Maximal CVC was attenuated in the HTN subjects by ~25% compared to AMN subjects (p<0.001). Throughout whole body heating %CVCmax was not different between the groups (HTN: 43±3 vs. AMN: 45±3%CVCmax, p>0.05). NOS-I significantly decreased %CVCmax in both groups but %CVCmax was greater in the HTN group (HTN: 32±4 vs. AMN: 23±3%CVCmax, p<0.05). The Ä%CVCmax between the control and NOS-I sites was attenuated at ÄTor>0.5°C in the HTN group (p<0.001 vs. AMN). A-I alone augmented %CVCmax only in the HTN group (HTN: 65±5 vs. AMN: 48±3%CVCmax, p<0.05). L-arg alone did not affect %CVCmax in either group (HTN: 49±5 vs. AMN: 49±3%CVCmax, p>0.05). Combined A-I+L-arg augmented %CVCmax in both subject groups compared to their respective control sites (HTN: 60±7 vs. AMN: 61±3%CVCmax, both p<0.05 vs. respective control sites). Vasodilatation is attenuated with HTN due to decreased NO-dependent vasodilation and can be augmented with arginase inhibition but not L-arg supplementation, suggesting that arginase is upregulated with HTN.
This article has been cited by other articles:
![]() |
E. L. Ritman, N. Charkoudian, A. Carpi, M. Rossi, P. J. Owen-Lynch, B. W. Wilkins, and C. Demougeot Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol, July 1, 2008; 105(1): 373 - 373. [Full Text] [PDF] |
||||
![]() |
L. A. Holowatz, C. S. Thompson-Torgerson, and W. L. Kenney The human cutaneous circulation as a model of generalized microvascular function J Appl Physiol, July 1, 2008; 105(1): 370 - 372. [Full Text] [PDF] |
||||
![]() |
L. A. Holowatz and W. L. Kenney Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1090 - H1096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |